28 related articles for article (PubMed ID: 11042382)
1. Binding Chromium(III) to Form Mixed Cr(III),Fe(III) Serum Transferrins.
Graham DR; Drummond E; Barrido M; Vincent JB
Biol Trace Elem Res; 2024 Jul; 202(7):3377-3382. PubMed ID: 37943387
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.
Zhao H; Wang S; Nguyen SN; Elci SG; Kaltashov IA
J Am Soc Mass Spectrom; 2016 Feb; 27(2):211-9. PubMed ID: 26392277
[TBL] [Abstract][Full Text] [Related]
3. An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium.
Jensen MP; Gorman-Lewis D; Aryal B; Paunesku T; Vogt S; Rickert PG; Seifert S; Lai B; Woloschak GE; Soderholm L
Nat Chem Biol; 2011 Jun; 7(8):560-5. PubMed ID: 21706034
[TBL] [Abstract][Full Text] [Related]
4. Urea Gel Electrophoresis in Studies of Conformational Changes of Transferrin on Binding and Transport of Non-Ferric Metal Ions.
Levina A; Wang B; Lay PA
Gels; 2021 Dec; 8(1):. PubMed ID: 35049554
[TBL] [Abstract][Full Text] [Related]
5. Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice.
García-Serran A; Ordoño J; DeGregorio-Rocasolano N; Melià-Sorolla M; Odendaal K; Martí-Sistac O; Gasull T
Antioxidants (Basel); 2023 Oct; 12(11):. PubMed ID: 38001798
[TBL] [Abstract][Full Text] [Related]
6. Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage.
DeGregorio-Rocasolano N; Martí-Sistac O; Ponce J; Castelló-Ruiz M; Millán M; Guirao V; García-Yébenes I; Salom JB; Ramos-Cabrer P; Alborch E; Lizasoain I; Castillo J; Dávalos A; Gasull T
Redox Biol; 2018 May; 15():143-158. PubMed ID: 29248829
[TBL] [Abstract][Full Text] [Related]
7. Anion binding properties of the transferrins. Implications for function.
Harris WR
Biochim Biophys Acta; 2012 Mar; 1820(3):348-61. PubMed ID: 21846492
[TBL] [Abstract][Full Text] [Related]
8. Iron mobilization from transferrin by therapeutic iron chelating agents.
Evans RW; Kong X; Hider RC
Biochim Biophys Acta; 2012 Mar; 1820(3):282-90. PubMed ID: 22155077
[TBL] [Abstract][Full Text] [Related]
9. Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS.
Nagaoka MH; Maitani T
Biochim Biophys Acta; 2001 May; 1526(2):175-82. PubMed ID: 11325539
[TBL] [Abstract][Full Text] [Related]
10. Binding patterns of co-existing aluminium and iron to human serum transferrin studied by HPLC-high resolution ICP-MS.
Nagaoka MH; Maitani T
Analyst; 2000 Nov; 125(11):1962-5. PubMed ID: 11193083
[TBL] [Abstract][Full Text] [Related]
11. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS.
Nagaoka MH; Yamazaki T; Maitani T
Biochem Biophys Res Commun; 2002 Sep; 296(5):1207-14. PubMed ID: 12207902
[TBL] [Abstract][Full Text] [Related]
12. Titanium preferential binding sites in human serum transferrin at physiological concentrations.
Nuevo-Ordoñez Y; Montes-Bayón M; Blanco González E; Sanz-Medel A
Metallomics; 2011 Dec; 3(12):1297-303. PubMed ID: 22041858
[TBL] [Abstract][Full Text] [Related]
13. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.
Nagaoka MH; Akiyama H; Maitani T
Analyst; 2004 Jan; 129(1):51-4. PubMed ID: 14737583
[TBL] [Abstract][Full Text] [Related]
14. Differed preferential iron-binding lobe in human transferrin depending on the presence of bicarbonate detected by HPLC/high-resolution inductively coupled plasma mass spectrometry.
Nagaoka MH; Maitani T
Biochim Biophys Acta; 2000 Oct; 1523(2-3):182-8. PubMed ID: 11042382
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
